Literature DB >> 17241836

Copper T 380A IUD and magnetic resonance imaging.

Miriam Zieman1, Emanuel Kanal.   

Abstract

BACKGROUND: Concerns about women who have implanted or in situ medical devices undergoing magnetic resonance (MR) imaging engender the need for testing. Prior testing of the Copper T 380A intrauterine device (IUD) has been done using MR systems of 1.5 T or less. This study was performed to test this IUD in a MR system of 3.0 T.
MATERIALS AND METHODS: In vitro safety testing was done via the Copper T 380A IUD using a GE Signa LX 3.0-T MR system. Variables tested included deflection, torque, heating and artifact.
RESULTS: No significant deflection, torque, heating or artifact was found in this in vitro testing model.
CONCLUSION: The outcomes measured revealed no safety concerns for the use of the Copper T 380A IUD at 3.0 T under the conditions of testing. This finding is compatible with the new standards adopted by the American Society for Testing and Materials and the Food and Drug Administration (FDA), with a rating of "MR Conditional."

Entities:  

Mesh:

Year:  2006        PMID: 17241836     DOI: 10.1016/j.contraception.2006.07.016

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Safety of intrauterine devices in MRI.

Authors:  Simon Bussmann; Roger Luechinger; Johannes M Froehlich; Constantin von Weymarn; Carolin Reischauer; Dow Mu Koh; Andreas Gutzeit
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

2.  Magnetic field interactions of copper-containing intrauterine devices in 3.0-Tesla magnetic resonance imaging: in vivo study.

Authors:  Vanessa Berger-Kulemann; Henrik Einspieler; Nilouparak Hachemian; Daniela Prayer; Siegfried Trattnig; Michael Weber; Ahmed Ba-Ssalamah
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

Review 3.  New developments in intrauterine device use: focus on the US.

Authors:  Anita L Nelson; Natasha Massoudi
Journal:  Open Access J Contracept       Date:  2016-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.